Why and when reexams can be a better option than inter partes reviews at the USPTO
The long read: There is growing evidence that patent litigants are turning to ex parte reexaminations to bolster their PTAB strategies. Cozen O’Connor’s Jeffrey Townes and Hongling Zou analyse why older tools deserve a second look and explore how to get best value from them
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.